Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2964958 | 0.98 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2966100 | 0.98 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2976999 | 0.98 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2971445 | 0.98 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL368248 | 0.98 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL2979522 | 0.98 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL8999804 | 0.98 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL6982564 | 0.95 | CYP1A2 (0.47) | CYP1A2EPHX1 | |
| SCHEMBL28727012 | 0.95 | CYP1A2 (0.42) | CYP1A2 | |
| SCHEMBL10713733 | 0.94 | CYP1A2 (0.44) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3930460-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| EP-3930461-A1 | ARTHROPOD CONTROLLING COMPOSITION | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| WO-2020239980-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH SA (CH) | 2020-12-03 | — | — | WO | claimed |
| WO-2020239954-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2020-12-03 | — | — | WO | claimed |
| US-12018226-B2 | Perfuming compositions | FIRMENICH SA (CH) | 2024-06-25 | — | — | US | disclosed |
| EP-3793514-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2021-03-24 | — | — | EP | disclosed |
| US-20200325415-A1 | PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2020-10-15 | — | — | US | disclosed |
| US-20190264133-A1 | PERFUMING COMPOSITIONS | FIRMENICH SA (CH) | 2019-08-29 | — | — | US | disclosed |
| US-20100113460-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
| EP-2139354-A2 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008116339-A2 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-10-02 | — | — | WO | disclosed |
| US-4132703-A | Stabilization of vinyl chloride polymers by means of lactone compounds | RHONE-POULENC INDUSTRIES (FR) | 1979-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113460-A1 | Organic Compounds | CYP2B6, CYP2A6, CYP2A13 | CYP1A2 11/4885EPHX1 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.